title: Maternal serum hormone concentrations for prediction of adverse outcome in threatened miscarriage.
abstract: Many serum markers have been investigated in attempts to predict the outcome of pregnancy in the first trimester, with varying degrees of success. The objective of this study was to investigate whether they can be related to pregnancy outcome in women presenting with first trimester threatened miscarriage. A cohort study of women attending the Early Pregnancy Unit of a London teaching hospital was studied. A total of 122 women presenting with bleeding in the first trimester and an ongoing pregnancy, and 33 women undergoing termination of pregnancy, were recruited. The main outcome measures were gestation at delivery, birth weight and the incidence of adverse pregnancy outcome. Inhibin A, activin A, human chorionic gonadotrophin (HCG), pregnancy-associated plasma protein-A and follistatin concentrations were all significantly lower in women who subsequently miscarried when compared with live births. Serum HCG concentrations were significantly higher in cases of threatened miscarriage compared with controls (P = 0.0009). Logistic regression analysis indicated that inhibin A alone provided the best predictor for first trimester miscarriage. This pilot study suggests that placental hormone concentrations could be useful in predicting adverse pregnancy outcome in women presenting with threatened miscarriage. Inhibin A was best at predicting the likelihood of subsequent miscarriage in this group.
authors.affiliation: Academic Department of Obstetrics and Gynaecology, Royal Free and University College London, UCL Campus London, 86-96 Chenies Mews, London WC1E 6HX, UK. j.johns@ucl.ac.uk
authors.forename: J
authors.initials: J
authors.lastname: Johns
authors.forename: S
authors.initials: S
authors.lastname: Muttukrishna
authors.forename: M
authors.initials: M
authors.lastname: Lygnos
authors.forename: N
authors.initials: N
authors.lastname: Groome
authors.forename: E
authors.initials: E
authors.lastname: Jauniaux
mesh_terms: D000033:Abortion, Threatened / Q000097:blood*; D028341:Activins / Q000097:blood; D000328:Adult; D015415:Biomarkers / Q000097:blood; D006063:Chorionic Gonadotropin / Q000097:blood; D004958:Estradiol / Q000097:blood; D005260:Female; D038681:Follistatin / Q000097:blood; D006801:Humans; D007265:Inhibins / Q000097:blood; D010865:Pilot Projects; D010926:Placental Hormones / Q000097:blood*; D011247:Pregnancy; D011256:Pregnancy Outcome; D011266:Pregnancy-Associated Plasma Protein-A / Q000032:analysis; D011374:Progesterone / Q000097:blood; D011446:Prospective Studies; D012044:Regression Analysis
chemical_list: D015415:Biomarkers; D006063:Chorionic Gonadotropin; D038681:Follistatin; D010926:Placental Hormones; C422405:activin A; C422362:inhibin A; D028341:Activins; D011374:Progesterone; D004958:Estradiol; D007265:Inhibins; D011266:Pregnancy-Associated Plasma Protein-A